{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-039221","form_type":"8-K","ticker":"AVTX","cik":"0001534120","company_name":"Avalo Therapeutics, Inc.","filed_at":"2024-09-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.423532+00:00","generated_at":"2026-05-31T06:25:46.760337+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Avalo Therapeutics regains Nasdaq compliance on market value standard; matter closed","bullets":["Received written confirmation from Nasdaq on Sept 3, 2024 that market value exceeded $35M for 10 consecutive trading days.","Regains compliance with Nasdaq Listing Rule 5550(b)(2) (Market Value of Listed Securities Standard).","Previously received notice on May 20, 2024 for non-compliance with Stockholders' Equity Requirement.","Compliance regained resolves the deficiency; no further Nasdaq action required."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-039221","json":"https://secwatch.observer/filing/0001628280-24-039221.json","markdown":"https://secwatch.observer/filing/0001628280-24-039221.md","text":"https://secwatch.observer/filing/0001628280-24-039221.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534120/000162828024039221/0001628280-24-039221-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534120/000162828024039221/avtx-20240903.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:25:46.760337+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}